| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.44e-06 | 114 | 62 | 6 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.35e-06 | 124 | 62 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 4.19e-06 | 137 | 62 | 6 | GO:0019783 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.87e-05 | 192 | 62 | 6 | GO:0008234 | |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 ADAMTS19 USP17L4 USP17L2 USP17L1 PCSK6 ADAMTS16 USP17L3 ADAMTS20 USP17L8 | 3.06e-05 | 654 | 62 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 5.12e-04 | 11 | 62 | 2 | GO:0004143 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 2.04e-06 | 125 | 62 | 6 | GO:0016579 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 4.65e-06 | 144 | 62 | 6 | GO:0070646 | |
| GeneOntologyBiologicalProcess | positive regulation of MDA-5 signaling pathway | 5.31e-05 | 4 | 62 | 2 | GO:1900245 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L4 HIF1A USP17L2 USP17L1 RNF144A USP17L3 BAZ1B RNF213 HERC1 USP17L8 FBXL5 | 7.21e-05 | 1074 | 62 | 12 | GO:0043687 |
| GeneOntologyBiologicalProcess | positive regulation of clathrin-dependent endocytosis | 8.84e-05 | 5 | 62 | 2 | GO:2000370 | |
| GeneOntologyBiologicalProcess | regulation of MDA-5 signaling pathway | 1.85e-04 | 7 | 62 | 2 | GO:0039533 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L4 HIF1A USP17L2 USP17L1 RNF144A USP17L3 RNF213 HERC1 USP17L8 FBXL5 | 1.86e-04 | 1009 | 62 | 11 | GO:0070647 |
| GeneOntologyCellularComponent | RAVE complex | 2.51e-05 | 3 | 61 | 2 | GO:0043291 | |
| Domain | UCH | 1.15e-07 | 71 | 61 | 6 | PF00443 | |
| Domain | USP_2 | 1.15e-07 | 71 | 61 | 6 | PS00973 | |
| Domain | USP_3 | 1.25e-07 | 72 | 61 | 6 | PS50235 | |
| Domain | USP_dom | 1.25e-07 | 72 | 61 | 6 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.25e-07 | 72 | 61 | 6 | IPR001394 | |
| Domain | USP_CS | 2.41e-06 | 66 | 61 | 5 | IPR018200 | |
| Domain | USP_1 | 3.23e-06 | 70 | 61 | 5 | PS00972 | |
| Domain | Rav1p_C | 1.05e-05 | 2 | 61 | 2 | IPR022033 | |
| Domain | Rav1p_C | 1.05e-05 | 2 | 61 | 2 | PF12234 | |
| Domain | PLAC | 1.18e-05 | 14 | 61 | 3 | PF08686 | |
| Domain | HABP4_PAI-RBP1 | 1.80e-05 | 16 | 61 | 3 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 1.80e-05 | 16 | 61 | 3 | IPR006861 | |
| Domain | PLAC | 3.09e-05 | 19 | 61 | 3 | PS50900 | |
| Domain | PLAC | 3.09e-05 | 19 | 61 | 3 | IPR010909 | |
| Domain | TSP_1 | 5.31e-05 | 63 | 61 | 4 | PF00090 | |
| Domain | ADAM_spacer1 | 5.60e-05 | 23 | 61 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 5.60e-05 | 23 | 61 | 3 | PF05986 | |
| Domain | TSP1 | 6.01e-05 | 65 | 61 | 4 | SM00209 | |
| Domain | TSP1_rpt | 6.01e-05 | 65 | 61 | 4 | IPR000884 | |
| Domain | TSP1 | 6.01e-05 | 65 | 61 | 4 | PS50092 | |
| Domain | Peptidase_M12B_ADAM-TS | 6.39e-05 | 24 | 61 | 3 | IPR013273 | |
| Domain | Ank_2 | 7.11e-05 | 215 | 61 | 6 | PF12796 | |
| Domain | - | 1.56e-04 | 248 | 61 | 6 | 1.25.40.20 | |
| Domain | ANK | 1.66e-04 | 251 | 61 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 1.73e-04 | 253 | 61 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.77e-04 | 254 | 61 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.77e-04 | 254 | 61 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 2.09e-04 | 262 | 61 | 6 | IPR002110 | |
| Domain | Peptidase_M12B_N | 2.79e-04 | 39 | 61 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.79e-04 | 39 | 61 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.00e-04 | 40 | 61 | 3 | PS00427 | |
| Domain | Reprolysin | 3.00e-04 | 40 | 61 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 3.00e-04 | 40 | 61 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.00e-04 | 40 | 61 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 3.00e-04 | 40 | 61 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 3.23e-04 | 41 | 61 | 3 | IPR001762 | |
| Domain | DAGK_acc | 4.64e-04 | 10 | 61 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 4.64e-04 | 10 | 61 | 2 | IPR000756 | |
| Domain | DAGKa | 4.64e-04 | 10 | 61 | 2 | SM00045 | |
| Domain | - | 6.30e-04 | 449 | 61 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 7.18e-04 | 459 | 61 | 7 | IPR013083 | |
| Domain | C1_1 | 8.56e-04 | 57 | 61 | 3 | PF00130 | |
| Domain | Ank | 8.85e-04 | 228 | 61 | 5 | PF00023 | |
| Domain | DAGKc | 9.31e-04 | 14 | 61 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.07e-03 | 15 | 61 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.07e-03 | 15 | 61 | 2 | PF00781 | |
| Domain | DAGK | 1.07e-03 | 15 | 61 | 2 | PS50146 | |
| Domain | ZF_DAG_PE_1 | 1.20e-03 | 64 | 61 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.20e-03 | 64 | 61 | 3 | PS50081 | |
| Domain | C1 | 1.25e-03 | 65 | 61 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 1.31e-03 | 66 | 61 | 3 | IPR002219 | |
| Domain | NAD/diacylglycerol_kinase | 1.38e-03 | 17 | 61 | 2 | IPR016064 | |
| Domain | PHD | 1.89e-03 | 75 | 61 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.20e-03 | 79 | 61 | 3 | IPR019787 | |
| Domain | EPHD | 2.32e-03 | 22 | 61 | 2 | PS51805 | |
| Domain | MetalloPept_cat_dom | 2.36e-03 | 81 | 61 | 3 | IPR024079 | |
| Domain | - | 2.36e-03 | 81 | 61 | 3 | 3.40.390.10 | |
| Domain | PHD | 3.08e-03 | 89 | 61 | 3 | SM00249 | |
| Domain | RING | 3.17e-03 | 305 | 61 | 5 | SM00184 | |
| Domain | Znf_PHD | 3.28e-03 | 91 | 61 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.71e-03 | 95 | 61 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 3.82e-03 | 96 | 61 | 3 | PS01359 | |
| Domain | ZINC_PROTEASE | 4.04e-03 | 98 | 61 | 3 | PS00142 | |
| Domain | Znf_RING | 4.20e-03 | 326 | 61 | 5 | IPR001841 | |
| Domain | CYSTEINE_SWITCH | 7.93e-03 | 41 | 61 | 2 | PS00546 | |
| Domain | BROMODOMAIN_2 | 7.93e-03 | 41 | 61 | 2 | PS50014 | |
| Pathway | REACTOME_RAS_PROCESSING | 4.82e-09 | 45 | 44 | 6 | MM15671 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.88e-06 | 191 | 44 | 7 | MM15289 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.51e-05 | 262 | 44 | 7 | MM15286 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 5.95e-05 | 221 | 44 | 6 | M27578 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.40e-04 | 39 | 44 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.40e-04 | 39 | 44 | 3 | MM15165 | |
| Pathway | REACTOME_DEUBIQUITINATION | 3.10e-04 | 299 | 44 | 6 | M27574 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 4.31e-04 | 318 | 44 | 6 | MM15278 | |
| Pathway | WP_HYPOXIADEPENDENT_DIFFERENTIATION_OF_MYOBLASTS | 7.27e-04 | 13 | 44 | 2 | MM15894 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 ADAMTS19 USP17L4 HIF1A USP17L2 USP17L1 RNF144A ADAMTS16 USP17L3 ADAMTS20 USP17L8 FBXL5 | 8.45e-04 | 1389 | 44 | 12 | MM15307 |
| Pathway | WP_HYPOXIADEPENDENT_SELFRENEWAL_OF_MYOBLASTS | 8.46e-04 | 14 | 44 | 2 | MM15832 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.23e-03 | 68 | 44 | 3 | M27303 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 5.23e-15 | 10 | 62 | 6 | 24207026 | |
| Pubmed | 2.29e-14 | 12 | 62 | 6 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 7.43e-14 | 14 | 62 | 6 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 6.67e-13 | 19 | 62 | 6 | 28067227 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 1.33e-12 | 21 | 62 | 6 | 8622927 | |
| Pubmed | 1.33e-12 | 21 | 62 | 6 | 14583620 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 1.33e-12 | 21 | 62 | 6 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 1.33e-12 | 21 | 62 | 6 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 1.33e-12 | 21 | 62 | 6 | 12447969 | |
| Pubmed | 1.33e-12 | 21 | 62 | 6 | 18980247 | ||
| Pubmed | 1.83e-12 | 22 | 62 | 6 | 9154835 | ||
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 3.29e-12 | 24 | 62 | 6 | 8995226 | |
| Pubmed | 4.32e-12 | 25 | 62 | 6 | 21115691 | ||
| Pubmed | 5.60e-12 | 26 | 62 | 6 | 35816173 | ||
| Pubmed | 1.15e-11 | 29 | 62 | 6 | 32527007 | ||
| Pubmed | 2.67e-11 | 33 | 62 | 6 | 20228807 | ||
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 20403174 | ||
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 17109758 | ||
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 20388806 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 3.24e-11 | 34 | 62 | 6 | 14699124 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 3.24e-11 | 34 | 62 | 6 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 3.24e-11 | 34 | 62 | 6 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 3.24e-11 | 34 | 62 | 6 | 20368735 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 3.24e-11 | 34 | 62 | 6 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 3.24e-11 | 34 | 62 | 6 | 19188362 | |
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 11941478 | ||
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 10936051 | ||
| Pubmed | 3.24e-11 | 34 | 62 | 6 | 21448158 | ||
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 3.90e-11 | 35 | 62 | 6 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 3.90e-11 | 35 | 62 | 6 | 21239494 | |
| Pubmed | 4.68e-11 | 36 | 62 | 6 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 5.57e-11 | 37 | 62 | 6 | 20228808 | |
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 17171436 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 3.74e-10 | 50 | 62 | 6 | 31806660 | |
| Pubmed | 7.32e-09 | 81 | 62 | 6 | 12838346 | ||
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 17342726 | ||
| Pubmed | 2.46e-08 | 48 | 62 | 5 | 16421571 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 15276201 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 12475935 | ||
| Pubmed | 4.78e-07 | 163 | 62 | 6 | 24316575 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.42e-06 | 15 | 62 | 3 | 16824795 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28526934 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31840352 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 27521280 | ||
| Pubmed | Histone methylase MLL1 coordinates with HIF and regulate lncRNA HOTAIR expression under hypoxia. | 9.37e-06 | 3 | 62 | 2 | 28756022 | |
| Pubmed | Effects of individual control of pH and hypoxia in chondrocyte culture. | 9.37e-06 | 3 | 62 | 2 | 19813243 | |
| Pubmed | 1.01e-05 | 75 | 62 | 4 | 20637190 | ||
| Pubmed | Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation. | 1.87e-05 | 4 | 62 | 2 | 25456127 | |
| Pubmed | FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2. | 1.87e-05 | 4 | 62 | 2 | 25956243 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 26551465 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 1.87e-05 | 4 | 62 | 2 | 28088271 | |
| Pubmed | Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance. | 1.87e-05 | 4 | 62 | 2 | 26642852 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 26468276 | ||
| Pubmed | Personalized copy number and segmental duplication maps using next-generation sequencing. | 3.12e-05 | 5 | 62 | 2 | 19718026 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 31405949 | ||
| Pubmed | Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. | 4.67e-05 | 6 | 62 | 2 | 25866973 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 16514417 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 33951475 | ||
| Pubmed | Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis. | 4.67e-05 | 6 | 62 | 2 | 32958928 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 9724755 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 11867212 | ||
| Pubmed | Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism. | 6.53e-05 | 7 | 62 | 2 | 23666760 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 25087979 | ||
| Pubmed | The actin regulator N-WASp is required for muscle-cell fusion in mice. | 6.53e-05 | 7 | 62 | 2 | 22736793 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 21962509 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 21425413 | ||
| Pubmed | The involvement of cytokine-like 1 (Cytl1) in chondrogenesis and cartilage metabolism. | 8.69e-05 | 8 | 62 | 2 | 32736681 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 20403915 | ||
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 1.12e-04 | 9 | 62 | 2 | 31844321 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 16364570 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 35021856 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 20193675 | ||
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 17021016 | ||
| Pubmed | 1.94e-04 | 674 | 62 | 7 | 37196079 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 34557486 | ||
| Pubmed | 2.47e-04 | 493 | 62 | 6 | 15368895 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 38018454 | ||
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 22438570 | ||
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 36227576 | ||
| Pubmed | Cdkn1c Boosts the Development of Brown Adipose Tissue in a Murine Model of Silver Russell Syndrome. | 4.18e-04 | 17 | 62 | 2 | 26963625 | |
| Pubmed | SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. | 4.18e-04 | 17 | 62 | 2 | 22318228 | |
| Pubmed | 4.73e-04 | 202 | 62 | 4 | 24639526 | ||
| Pubmed | PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis. | 5.24e-04 | 19 | 62 | 2 | 28049691 | |
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 12743021 | ||
| Pubmed | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. | 6.42e-04 | 21 | 62 | 2 | 20195266 | |
| Pubmed | 8.40e-04 | 103 | 62 | 3 | 32744500 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 19590010 | ||
| Pubmed | 1.06e-03 | 251 | 62 | 4 | 31076518 | ||
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 26442671 | ||
| Pubmed | 1.15e-03 | 28 | 62 | 2 | 28847650 | ||
| Pubmed | 1.15e-03 | 28 | 62 | 2 | 31719045 | ||
| Pubmed | Maternal diabetes alters transcriptional programs in the developing embryo. | 1.50e-03 | 32 | 62 | 2 | 19538749 | |
| Pubmed | 1.59e-03 | 33 | 62 | 2 | 18424556 | ||
| Pubmed | 1.64e-03 | 709 | 62 | 6 | 22988430 | ||
| Interaction | POTEG interactions | 4.89e-06 | 12 | 58 | 3 | int:POTEG | |
| Interaction | POTEC interactions | 6.34e-06 | 13 | 58 | 3 | int:POTEC | |
| Interaction | POTEH interactions | 8.14e-06 | 2 | 58 | 2 | int:POTEH | |
| Interaction | POTED interactions | 4.87e-05 | 4 | 58 | 2 | int:POTED | |
| Interaction | ADAMTS19 interactions | 8.10e-05 | 5 | 58 | 2 | int:ADAMTS19 | |
| Cytoband | 8p23.1 | 6.80e-08 | 154 | 62 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 7.96e-07 | 234 | 62 | 6 | chr8p23 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.08e-10 | 13 | 46 | 5 | 685 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.45e-05 | 19 | 46 | 3 | 50 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.81e-04 | 10 | 46 | 2 | 1178 | |
| GeneFamily | Ankyrin repeat domain containing | 3.61e-04 | 242 | 46 | 5 | 403 | |
| GeneFamily | PHD finger proteins | 1.55e-03 | 90 | 46 | 3 | 88 | |
| GeneFamily | Ring finger proteins | 5.18e-03 | 275 | 46 | 4 | 58 | |
| Coexpression | MADAN_DPPA4_TARGETS | 5.02e-08 | 86 | 61 | 6 | MM1312 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | 2.44e-07 | 112 | 61 | 6 | MM1095 | |
| Coexpression | GERY_CEBP_TARGETS | 1.98e-06 | 160 | 61 | 6 | MM1155 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP | 4.93e-05 | 171 | 61 | 5 | M6746 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 6.36e-05 | 92 | 61 | 4 | MM503 | |
| Coexpression | NOTCH_DN.V1_UP | 7.35e-05 | 186 | 61 | 5 | M2789 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 8.23e-05 | 309 | 61 | 6 | MM1244 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | WASL DMXL2 PCSK6 TAFA1 ADAMTS16 RNF213 SCAF11 HERC1 RNF145 DMXL1 | 1.23e-05 | 770 | 51 | 10 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | WASL DMXL2 PCSK6 ADAMTS16 RNF213 DGKD SCAF11 HERC1 RNF145 DMXL1 | 1.35e-05 | 778 | 51 | 10 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.99e-05 | 138 | 51 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 2.02e-05 | 67 | 51 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.67e-05 | 387 | 51 | 7 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 4.82e-05 | 404 | 51 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.11e-05 | 168 | 51 | 5 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 8.51e-05 | 776 | 51 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.02e-04 | 795 | 51 | 9 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500 | 1.57e-04 | 113 | 51 | 4 | gudmap_developingGonad_e16.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 1.72e-04 | 45 | 51 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.78e-04 | 219 | 51 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.23e-04 | 230 | 51 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.37e-04 | 233 | 51 | 5 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 3.01e-04 | 134 | 51 | 4 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 3.18e-04 | 387 | 51 | 6 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.94e-04 | 403 | 51 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.15e-04 | 424 | 51 | 6 | geo_heart_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200 | 5.49e-04 | 157 | 51 | 4 | gudmap_developingGonad_P2_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.79e-04 | 797 | 51 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_100 | 5.82e-04 | 15 | 51 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 6.13e-04 | 804 | 51 | 8 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 6.24e-04 | 806 | 51 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.69e-06 | 195 | 62 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.08e-06 | 197 | 62 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.54e-11 | 69 | 54 | 7 | DOID:1682 (implicated_via_orthology) | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 2.50e-10 | 46 | 54 | 6 | DOID:5426 (implicated_via_orthology) | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 1.17e-04 | 9 | 54 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Varicose veins | 4.35e-04 | 193 | 54 | 4 | HP_0002619 | |
| Disease | response to perphenazine | 1.04e-03 | 26 | 54 | 2 | GO_0097334 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.34e-03 | 447 | 54 | 5 | EFO_0000694, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKWDMSAENARCKVC | 1176 | Q9UIG0 | |
| KCVWQCKTSVSVHLM | 161 | Q8TDJ6 | |
| CIWHCKTASQVHLMK | 161 | Q9Y485 | |
| LWCHRIGRKCETKFM | 541 | Q8TE57 | |
| CMHLWCTSTEKLHKG | 506 | P59510 | |
| QEMQHVICTGLWCKV | 581 | Q8TE59 | |
| HCLMWACKACKRKST | 66 | P13349 | |
| WCHDNKSRLRKMKSC | 181 | Q7L5Y9 | |
| HRWCCNKKNAVVMDQ | 266 | P43628 | |
| TMNIKSATWKVLHCT | 181 | Q16665 | |
| VAVLKKSLCMVKCHW | 576 | Q96PV6 | |
| AHQNRVMTCVWCNKK | 3426 | Q15751 | |
| MVGLTACLKAWKEHC | 641 | Q8IY21 | |
| KKWTAVPSQHMCVAA | 491 | P29122 | |
| GRWKACNTCASHLMV | 236 | Q8NGJ0 | |
| SCRMSATQCLKHEWL | 756 | Q32MK0 | |
| WSSQKMDHILICCVC | 311 | O94880 | |
| KACRMEFCSTCKASW | 136 | P50876 | |
| MKTLRSKMGKWCCHC | 91 | A0JP26 | |
| RRHCCFAKMTWNAKR | 6 | O43825 | |
| KWKMLWITSCVCQRN | 326 | O95389 | |
| KACTSICQWVRAMHK | 3031 | Q9P2D7 | |
| WKCLRMKVFVCCAST | 156 | P52797 | |
| CQMERRCKASWDHLK | 1166 | Q2V2M9 | |
| CLSWMSLKWTQAVHC | 51 | O60756 | |
| IHMDICWKKVTNDVC | 1581 | Q14767 | |
| HKTNIKMRCEFLACW | 26 | Q9Y5P2 | |
| RCLWCKAMVHTSCKE | 266 | Q16760 | |
| MQCGKCDRWVHSKCE | 1586 | Q03164 | |
| CRCSQVSMKWSQLTK | 226 | Q9UKA1 | |
| CIWCQKTVHDECMKN | 156 | P52429 | |
| MKCNGKESRIWQCHS | 786 | Q86VB7 | |
| RSKTACKHLWKCSVE | 276 | Q9HCS5 | |
| HVFCMTCILKWAETL | 61 | Q99590 | |
| CSWMTHQSCMFLVKS | 46 | Q9HBR0 | |
| ECTERKMCVNAHVWT | 521 | Q9BXB4 | |
| MKTLRSKMGKWCCHC | 91 | B2RU33 | |
| WMCATGNKIKTTRIH | 116 | Q7Z5A9 | |
| WKAHMNAKRCPHCKT | 196 | O95602 | |
| ITLCKHESILKWMCN | 416 | P48380 | |
| MKTLRSKMGKWCCHC | 91 | P0CG38 | |
| THQCWKALLMKKCNG | 271 | Q9H2U2 | |
| HCCGAKRIMKEAFRW | 176 | Q96AQ7 | |
| ARTCRDLKMCHSDWK | 1256 | P02452 | |
| RKSVVHCSKIWSCRK | 4731 | Q63HN8 | |
| KCCMLCTMQAHITWA | 121 | A6NCW0 | |
| AKQCRKWLCNMSIDT | 511 | Q8IWX7 | |
| KCCMLCTMQAHITWA | 121 | A6NCW7 | |
| CKMCKVSVHLWCSEE | 141 | Q6ZMT1 | |
| KCCMLCTMQAHITWA | 121 | Q7RTZ2 | |
| CVHSHWTVCGQKMSK | 336 | Q96GW9 | |
| ISMKNHFCKCDSVSW | 201 | Q9UJU3 | |
| MHGKNWSKLCKDCQV | 71 | O94811 | |
| KCCMFCTMQAHITWA | 121 | P0C7H9 | |
| KCCMLCTMQAHITWA | 121 | P0C7I0 | |
| VRGIQVRMKWCATCH | 96 | Q9ULC8 | |
| ADRNCMWSKKCSGVA | 51 | O00401 | |
| QRVHMGEKTWKCREC | 671 | Q9NZL3 | |
| LCSCVMKTKQIWLFS | 136 | Q96MT1 | |
| MKTLRSKMGKWCCHC | 91 | Q6S5H5 | |
| MKTLRSKMGKWCCHC | 91 | Q6S545 | |
| MKTLRSKMGKWCCHC | 91 | A6NI47 | |
| KCCMLCTMQAHITWA | 121 | Q6R6M4 |